Global Transcatheter Devices Market to Surge to $21.48
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Page 2 - Venus Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Venus Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Venus Medtech Today - Breaking & Trending Today
Rising Prevalence of Cardiac Diseases and Minimally Invasive Procedures Propel the Transcatheter Devices Market to Grow at 12.26% CAGR
/PRNewswire/ -- The "Global Transcatheter Devices Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19 and...
Source: prnewswire.com
Unveiling the Future of Heart Health: Transcatheter
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Transcatheter Pulmonary Valves - Global Strategic Business Report" report has been added to ...
Source: globenewswire.com
Aortic Innovation on the Rise: Global TAVI Market to Reach $14.08 Billion by 2030, Growing at 13.7% CAGR
/PRNewswire/ -- The "Transcatheter Aortic Valve Implantation (TAVI) Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape...
Source: prnewswire.com
VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally
Recently, Venus Medtech (Hangzhou) Inc. ("Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced the Investigational Device Exemption (IDE) full approval for its in-house developed VenusP-Valve from the U.S. Food and Drug Administration (FDA). VenusP-Valve, thus, has become the first China-developed heart valvular system to be approved by the FDA for clinical trial, setting a new milestone in the global footprint of C
Source: yahoo.com